United States · FDA National Drug Code directory
Cyclobenzaprine Hydrochloride
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 65862-190_13f9bb96-7677-4506-befe-d7afa9b13cab
- Product NDC
- 65862-190
- Form
- TABLET, FILM COATED
- Composition / generic term
- Cyclobenzaprine Hydrochloride
- Labeler
- Aurobindo Pharma Limited
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20080926
- Source listing expiry
- 20261231
Source-listed ingredients
- CYCLOBENZAPRINE HYDROCHLORIDE — 5 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 TABLET, FILM COATED in 1 BOTTLE (65862-190-01) · 65862-190-01
- 500 TABLET, FILM COATED in 1 BOTTLE (65862-190-05) · 65862-190-05
- 1000 TABLET, FILM COATED in 1 BOTTLE (65862-190-99) · 65862-190-99
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →